
北美左心室辅助装置市场预测至 2028 年 – COVID-19 影响和区域分析 – 血流类型(脉动血流和非脉动血流)、设计(植入式心室辅助装置和经皮心室辅助装置)以及申请(移植桥梁、目的地治疗、康复桥梁和候选桥梁)
No. of Pages: 104 | Report Code: BMIRE00027951 | Category: Life Sciences
No. of Pages: 104 | Report Code: BMIRE00027951 | Category: Life Sciences
老年人口的增加有助于北美左心室辅助设备市场的增长
老年人群容易患心血管疾病、骨科疾病、代谢紊乱和神经系统疾病等疾病。根据美国人口普查局的数据,2009 年美国约有 13% 的人口年龄在 65 岁及以上,预计到 2030 年底这一数字将增加 20%。根据美国埃默里医疗保健公司的一项研究,~ 140万65岁以上的人患有充血性心力衰竭,超过5%的60-69岁的人患有充血性心力衰竭。此外,65 岁及以上人群中充血性心力衰竭的年发病率为千分之 10。充血性心力衰竭是 65 岁及以上患者最常见的诊断之一,2021 年美国有 875,000 人因该病住院。左心室辅助装置广泛用于治疗老年人群的终末期心力衰竭。因此,老龄化人口基数的增加和心力衰竭患病率的增加推动了北美左心室辅助装置市场的发展。
北美左心室辅助装置市场概览
北美左心室辅助装置市场细分为美国、加拿大和墨西哥。由于心血管疾病的流行,特别是在老年人群中,该地区在 2021 年占据全球左心室辅助装置市场的最大份额。心力衰竭病例的增加以及将 LVAD 相关费用纳入保险也促进了北美左心室辅助装置市场的增长。
到 2028 年北美左心室辅助装置市场收入及预测(百万美元)
  ;
p>
北美左心室辅助装置市场细分
北美左心室辅助装置市场根据流程类型、设计和应用以及国家/地区进行细分。
根据血流类型,北美左心室辅助装置市场分为非脉动血流和脉动血流。 非脉动细分市场在 2022 年获得了更大的市场份额。
北美左心室辅助装置根据设计,市场分为植入式心室辅助装置和经皮心室辅助装置。 托管服务细分市场在2022年占据了更大的市场份额。
在应用方面,北方美国左心室辅助装置市场分为目的地治疗、移植桥梁、候选桥梁和康复桥梁。 目标治疗细分市场在 2022 年占据最大市场份额。
北美左心室辅助装置市场按国家/地区分为美国、加拿大和墨西哥。 2022 年美国将主导市场。
AO 卡巴斯基实验室; Avast 软件公司;思科系统公司; ESET、spol。 s 罗;飞塔公司;迈克菲有限责任公司;微软公司;和 Palo Alto Networks, Inc. 是北美左心室辅助设备市场的领先公司。
Strategic insights for North America Left Ventricular Assist Device involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 540.59 Million |
Market Size by 2028 | US$ 739.28 Million |
Global CAGR (2022 - 2028) | 5.4% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 流动类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Left Ventricular Assist Device refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Left Ventricular Assist Device Market is valued at US$ 540.59 Million in 2022, it is projected to reach US$ 739.28 Million by 2028.
As per our report North America Left Ventricular Assist Device Market, the market size is valued at US$ 540.59 Million in 2022, projecting it to reach US$ 739.28 Million by 2028. This translates to a CAGR of approximately 5.4% during the forecast period.
The North America Left Ventricular Assist Device Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Left Ventricular Assist Device Market report:
The North America Left Ventricular Assist Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Left Ventricular Assist Device Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Left Ventricular Assist Device Market value chain can benefit from the information contained in a comprehensive market report.